Jan-Henning is an ERC grant-holder, Professor, and Director of Pediatrics & Pediatric Oncology at the University Hospital of Halle.
Dirk is a Max Eder Fellow and Professor at the University Hospital of Halle. He specializes in CRISPR-Cas9 systems and modeling leukemia in mice.
Raj (postdoctoral fellow) works on patient-dervied xenograft models of pediatric AML, in vivo non-coding RNA studies, and pre-clinical drug testing.
Daniela (postdoctoral fellow) works on mapping the interactomes of the GATA1 / GATA1s transcription factors.
Hasan (postdoctoral fellow) works on delivering lipid nanoparticle-based oligonucleotides into AML cells, towards RNA-centered therapeutic options.
David (medical student, UKH) is performing drug testing on patient-dervied xenografts in vivo to find new potential therapies for childhood AML.
Oriol (PhD student, independent) is investigating the interactive genetic network of the stem cell microRNA cluster miR-99a/105~125b.
Michelle (PhD student, HBRS Molecular Medicine) is using a CRISPR interference-based screening platform to investigate long non-coding RNAs in AML.
Lonneke (PhD student, independent) is investigating interactions within the DLK1-DIO3 non-coding RNA locus in normal and malignant megakaryopoiesis.
Sofia (PhD student, HBRS Molecular Medicine) is studying the interplay between chromosome 21 genes and GATA1s in Down syndrome AML.
Dorit (PhD student, HBRS Molecular Medicine) is studying the deregulated network in Ezh2-mutated AML using state-of-the-art CRISPR-Cas9 technology.
Lucie (technician) supports the in vitro aspect of all non-coding RNA projects.
Maurice (PhD student, HBRS Molecular Medicine) is using a lentiviral CRISPR-Cas9 system to model Down syndrome AML in vivo and in vitro.